- 英文名称17-(2-Chloroacetyl)-9-Fluoro-11-Hydroxy-10,13,16-Trimethyl-7,8,11,12,14,15-Hexahydro-6H-Cyclopenta[a]Phenanthren-3-One
- 中文名称丙酸氯倍米松杂质B
- IUPAC名称(8S,9R,10S,11S,13S,14S)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one
- CAS编号1356190-17-4
- MFCD编号:MFCD20264923
- EINECS号:809-045-8
- FDA UNII编号:K1QBD46YKR
- 分子式:C22H26ClFO3分子量:392.9
- 产品CID: 557406
- 产品分类分析化学 → 分析试剂 → 离子色谱试剂
- 相似结构搜索
- InChIKey: YWRGNRUKHBYFTD-QEYSUVLUSA-N
- 1S/C22H26ClFO3/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,24)18(27)10-20(16,2)19(12)17(26)11-23/h6-7,9,15-16,18,27H,4-5,8,10-11H2,1-3H3/t15-,16-,18-,20-,21-,22-/m0/s1
- 计算化学: 氢键受体数4.0氢键供体数1.0可旋转键数2.0
欧盟法规
C&L通报海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2905122000-异丙醇
2912110000-甲醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-4404141-A
优先权日:1981-03-09
标 题:Δ9(11) - And Δ16 -21-chloro-20-keto steroids of the pregnane and D-homopregnane series, their preparation and use as intermediates for the synthesis of highly effective corticoids
发明人:ANNEN KLAUS; LAURENT HENRY; HOFMEISTER HELMUT
权利人:SCHERING AG
摘要:Δ 16 - and Δ 17 -21-chloro-20-keto steroids of the formula ##STR1## wherein n is 1 or 2, n C 1 C 2 and C 9 C 11 represent a CC-single or CC-double bond, n R 1 is H or OH, n R 2 is H or CH 3 , n R 3 is H or F wherein, when R 3 =F, C 9 C 11 is a CC-single bond, and n R 4 is H, CH 3 , or F, n are valuable intermediates for preparation of highly effective, known steroids. n A process for preparing these compounds involves heating the corresponding 11β- and/or 17α- or 17aα-nitrooxy-21-mesyloxy-20-keto steroids with lithium chloride in a dipolar aprotic solvent at temperatures above room temperature.
专利号:EP-0061416-B1
优先权日:1981-03-09
标题 :Process for the preparation of delta 9(11)- and delta 16-21-chloro-20-keto steroids of the pregnane and d-homopregnane series and their use as intermediates for the synthesis of highly effective corticoids
专利号:EP-0061416-A1
优先权日:1981-03-09
标题 :Process for the preparation of Delta 9(11)- and delta 16-21-chloro-20-keto steroids of the pregnane and D-homopregnane series and their use as intermediates for the synthesis of highly effective corticoids